如何在患有肝病的患者中管理脊柱静脉血栓症
Nicoletta Riva1, Walter Ageno2
1Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
在肝硬化患者的脊柱静脉血栓症 (SVT) 抗凝剂治疗显著改善了结果,降低了死亡率并增加了血管再通道. 早期抗凝治疗对于更好的预后和管理并发症至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血管医学 血管医学
- 血栓形成研究研究
背景情况:
- 肝硬化是状静脉血栓症 (SVT),特别是门静脉血栓症的重要危险因素.
- 在SVT患者中,SVT发生在24-28%的患者中,在肝硬化中,SVT的综合发病率为每100个患者年4.6.
结论:
- 在肝硬化患者中,急性SVT应常规处方抗凝药,除非出血风险禁用.
- 标准治疗包括低分子量肝素,其次是口服抗凝剂,由于持续的血栓形成风险,建议长期治疗.
更多相关视频
相关概念视频
01:28Esophageal Varices-II: Clinical Features and Management
71
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
71
01:24Esophageal Varices-I: Introduction
149
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
149